Comparing survival in patients with chronic kidney disease across three countries: Results from the study of heart and renal protection-extended review

Benjamin Talbot, Alan Cass, Robert Walker, Lai Hooi, Meg Jardine, Min Jun, Kris Rogers, Louisa Sukkar, Brendan Smyth, Martin Gallagher

Research output: Contribution to journalArticlepeer-review

22 Downloads (Pure)

Abstract

Aim: This study examined whether survival and causes of death differed between participants enrolled from Australia (AUS), Malaysia (MYL), and New Zealand (NZ) in extended follow-up of the Study of Heart and Renal Protection (SHARP), a randomized controlled trial (RCT) of participants with moderate to severe chronic kidney disease comparing placebo to combination therapy with Simvastatin and Ezetimibe. Methods: All participants alive at final SHARP study visit in participating centres were eligible for inclusion. Consenting participants were re-enrolled following final SHARP Study visit and followed for 5 years. Data collection included: significant medical events, hospital admissions and requirement for kidney replacement therapy. Data linkage was performed to national kidney and mortality registries. The primary outcome was all-cause mortality compared across the three countries. Results: The SHARP trial randomized 2029 participants from AUS (1043/2029, 51%), MYL (701/2029, 35%), and NZ (285/2029, 14%), with 1136 participants alive and eligible for extended follow-up at the end of SHARP. In multivariable analysis, risk of death was increased for participants in MYL (HR 1.37, 95% CI 1.17–1.61, p <.001) and NZ (HR 1.28, 95% CI 1.04–1.57, p =.02) when compared to AUS participants. Adjustment for kidney transplantation as a competing risk did not explain the variation seen between countries. Conclusion: This study allows a better understanding of the differences in long-term mortality risk across participants from AUS, MYL, and NZ in extended follow-up of the SHARP study and demonstrates the feasibility and value of extended follow-up of participants enrolled in RCTs.

Original languageEnglish
Pages (from-to)36-43
Number of pages8
JournalNephrology
Volume28
Issue number1
Early online date30 Oct 2022
DOIs
Publication statusPublished - Jan 2023

Fingerprint

Dive into the research topics of 'Comparing survival in patients with chronic kidney disease across three countries: Results from the study of heart and renal protection-extended review'. Together they form a unique fingerprint.

Cite this